{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:02Z","timestamp":1786120262155,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/wnf.0b013e3182329670","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T04:18:36Z","timestamp":1321676316000},"page":"260-261","source":"Crossref","is-referenced-by-count":6,"title":["Delayed-Onset Obsessive-Compulsive Symptoms After Brain Infarctions Treated With Paroxetine"],"prefix":"10.1097","volume":"34","author":[{"given":"Katsumasa","family":"Muneoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Shirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2190\/EUMY-3MGP-MWB2-CWG9","article-title":"Neuropsychiatric aspects of stroke.","volume":"21","author":"Beckson","year":"1991","journal-title":"Int J Psychiatry Med"},{"key":"R2-12-20210203","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00415-009-5083-9","article-title":". Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction.","volume":"256","author":"Benejam","year":"2009","journal-title":"J Neurol"},{"key":"R3-12-20210203","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.neuroimage.2004.07.069","article-title":". Spatiotemporal patterns of language-specific brain activity in patients with chronic aphasia after stroke using magnetoencephalography.","volume":"23","author":"Breier","year":"2004","journal-title":"Neuroimage"},{"key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.09.003","article-title":". Locomotion outcome in hemiplegic patients with middle cerebral artery infarction: the difference between right- and left-sided lesions.","volume":"18","author":"Goto","year":"2009","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R5-12-20210203","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1440-1819.2007.01635.x","article-title":". Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine.","volume":"61","author":"Matsui","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroimage.2005.05.009","article-title":". Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects.","volume":"27","author":"Gerdelat-Mas","year":"2005","journal-title":"Neuroimage"},{"key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroimage.2004.12.023","article-title":". Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer.","volume":"27","author":"Loubinoux","year":"2005","journal-title":"Neuroimage"},{"key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00213-007-0939-0","article-title":"Paroxetine-induced modulation of cortical activity supporting language representations of action.","volume":"195","author":"Peran","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"R9-12-20210203","first-page":"114","article-title":"Peran P, de Boysson C, et al..","volume":"102","author":"de Boissezon","year":"2007","journal-title":"Pharmacotherapy of aphasia: myth or reality Brain Lang"},{"key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":". Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"R11-12-20210203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archpsyc.59.3.250","article-title":". Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.","volume":"59","author":"Saxena","year":"2002","journal-title":"Arch Gen Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201111000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:23:37Z","timestamp":1786047817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201111000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3182329670","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}